Zdrowie i gospodarka · 11/10/2022

FDA Extends Comment Period for LASIK Laser Labeling Guidance

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on patient labeling recommendations for LASIK lasers, in response to industry requests for more time to submit comments.